Position in HCM
as of Dec 31, 2025
· filed Feb 24, 2026
Position Value
$1,719
-$312 QoQ
Shares Held
129
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2024
7 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in HCM Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Bell Investment Advisors, Inc holds $125,074 across 19 Drug Manufacturers - Specialty & Generic names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
41 | $24,312 | |
| 2 | RDY |
Dr Reddys Laboratories Ltd
|
1,724 | $23,877 | |
| 3 | TAK |
Takeda Pharmaceutical Co Ltd
|
905 | $16,760 | |
| 4 | ZTS |
Zoetis Inc.
|
83 | $9,811 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
|
67 | $8,826 | |
| 6 | ELAN |
Elanco Animal Health Inc
|
288 | $6,891 | |
| 7 | HLN |
Haleon plc
|
660 | $6,606 | |
| 8 | VTRS |
Viatris Inc
|
466 | $6,295 |
All Filings in HCM
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2025-12-31 | $1,719 | 129 | Shares | Sole | 2026-02-24 | |
| 2025-09-30 | $2,031 | 129 | Shares | Sole | 2025-11-21 | |
| 2025-03-31 | $556 | 37 | Shares | Sole | 2025-05-16 | |
| 2024-12-31 | $533 | 37 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $722 | 37 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $633 | 37 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $621 | 37 | Shares | Sole | 2024-05-08 | |
| No filing history on record for this holder in this stock. | ||||||